Neoadjuvant Therapy Before Radical Prostatectomy For Clinical T3/T4 Carcinoma of the Prostate: 5-Year Followup, Phase II Southwest Oncology Group Study 9109-Reference-Cited by-同舟云学术

Neoadjuvant Therapy Before Radical Prostatectomy For Clinical T3/T4 Carcinoma of the Prostate: 5-Year Followup, Phase II Southwest Oncology Group Study 9109

Published:2002-11 Issue: Volume: Page:2016-2019
ISSN:0022-5347
Container-title:The Journal of Urology
language:en
Short-container-title:The Journal of Urology

Author:

POWELL ISAAC J.,TANGEN CATHERINE M.,MILLER GARY J.,LOWE BRUCE A.,HAAS GABRIEL,CARROLL PETER R.,OSSWALD MICHAEL B.,deVERE WHITE RALPH,THOMPSON IAN M.,CRAWFORD E. DAVID

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference10 articles.

1. ENDOCRINE THERAPY IN CARCINOMA OF THE PROSTATE

2. Combined Hormone Control Therapy and Radical Prostatectomy in the Treatment of Selected Cases of Advanced Carcinoma of the Prostate: A Retrospective Study Based Upon 25 Years of Experience

3. NEOADJUVANT ANDROGEN ABLATION BEFORE RADICAL PROSTATECTOMY IN cT2bNxMo PROSTATE CANCER: 5-YEAR RESULTS

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing results after surgery in patients with clinical unilateral T3a prostate cancer treated with or without neoadjuvant androgen-deprivation therapy;BJU International;2007-02

2. Improving outcomes in early prostate cancer: Part II ? neoadjuvant treatment;BJU International;2006-10

3. Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma;BJU International;2006-08

4. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome;BJU International;2005-04

5. Advanced prostate cancer treatment guidelines: a United States perspective;BJU International;2004-12